Charles River Laboratories International (CRL) Exchange Rate Effect (2009 - 2026)
Charles River Laboratories International (CRL) posted Exchange Rate Effect of -$781000.0 for Q2 2026, down 162.58% on a QoQ basis from $1.2 million in Q1 2026, and down 106.16% year-over-year from $12.7 million in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Exchange Rate Effect for 18 years, with the latest figure at -$781000.0 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 106.16% year-over-year to -$781000.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a 88.83% decrease from a year earlier, with the FY2025 full-year figure at $18.8 million, up 207.75% from the prior year.
- Exchange Rate Effect was -$781000.0 for Q2 2026 at Charles River Laboratories International, down from $1.2 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $14.9 million in Q4 2022, with the low at -$13.4 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is $2.0 million, with a median of $1.5 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect surged 6776.39% in 2022, then sank 20526.67% in 2023.
- Over 5 years, Exchange Rate Effect stood at $14.9 million in 2022, then fell by 14.33% to $12.7 million in 2023, then slumped by 205.7% to -$13.4 million in 2024, then jumped by 129.21% to $3.9 million in 2025, then sank by 119.88% to -$781000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$781000.0 (Q2 2026), $1.2 million (Q1 2026), and $3.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -1.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 221,000.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -1.60 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -781,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -800,000.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 43,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -101,842.56 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -781,000.00 |
| Mar 28, 2026 | 1.25 Mn |
| Dec 27, 2025 | 3.93 Mn |
| Sep 27, 2025 | -3.03 Mn |
| Jun 28, 2025 | 12.67 Mn |
| Mar 29, 2025 | 5.27 Mn |
| Dec 28, 2024 | -13.45 Mn |
| Sep 28, 2024 | 7.70 Mn |
| Jun 29, 2024 | -3.34 Mn |
| Mar 30, 2024 | -8.39 Mn |
| Dec 30, 2023 | 12.72 Mn |
| Sep 30, 2023 | -6.19 Mn |
| Jul 1, 2023 | -163,000.00 |
| Apr 1, 2023 | 1.67 Mn |
| Dec 31, 2022 | 14.85 Mn |
| Sep 24, 2022 | -30,000.00 |
| Jun 25, 2022 | 5.02 Mn |
| Mar 26, 2022 | 5.74 Mn |
| Dec 25, 2021 | 216,000.00 |
| Sep 25, 2021 | 448,000.00 |